FRANKLIN LAKES, N.J. , Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery... Read More

FRANKLIN LAKES, N.J. , Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboration. Together, BD and Opentrons will integrate robotic liquid-handling capabilities into BD single-cell multiomics... Read More

SUMTER, S.C. , Oct. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout its history has been a core site within the Company's extensive U.S. manufacturing footprint. Since opening its doors and producing its first glass syringe barrel in 1970... Read More

FRANKLIN LAKES, N.J. , Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the future, with an initial focus on a robotic solution that will enable patients to pick up select prescriptions at their convenience — 24 hours a day, seven days a... Read More

FRANKLIN LAKES, N.J. , Sept. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke's Hospital of the University of Cambridge, United Kingdom . Together with its comprehensive menu of assays for DNA, RNA, and protein analysis, the... Read More

FRANKLIN LAKES, N.J. , Sept. 2, 2025 /PRNewswire/ -- In recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE: BDX) is shining a spotlight on a serious yet often overlooked circulatory disorder that restricts blood flow to the limbs and is a leading cause of preventable amputations. PAD affects more than 21 million Americans 1 and more than 200 million people globally. 2... Read More

FRANKLIN LAKES, N.J. , Aug. 14, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025 at 8:00 a.m. Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will... Read More

Revenue of $5.5 billion increased 10.4% as reported, 8.5% adjusted FXN and 3.0% organic GAAP and adjusted diluted EPS grew to $2.00 and $3.68 , respectively GAAP and adjusted gross margin up 160 basis points and 50 basis points, respectively, driven by BD Excellence GAAP and adjusted operating income up 46.6% and 11.3%, respectively Company raises full-year adjusted diluted EPS guidance to $14.30 to $14.45 , reflecting an... Read More

FRANKLIN LAKES, N.J. , Aug. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative's (HIRC)... Read More

FRANKLIN LAKES, N.J. , Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, Neb. facility to increase the resiliency of the U.S. health care system. The investments will support new BD® PosiFlush™ Prefilled... Read More

New FDA Submission Includes Self-Collection Swab and High-Tech Laboratory Robotics that Report More High-Risk HPV Strains Than Any Other Test FRANKLIN LAKES, N.J. , July 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted an application to the U.S. Food and Drug Administration for a new, at-home human papillomavirus (HPV) test... Read More

New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J. , July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Veritor™ System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in... Read More

FRANKLIN LAKES, N.J. , July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics. The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more... Read More

FRANKLIN LAKES, N.J. , July 22, 2025 /PRNewswire/ -- The Board of Directors of BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on September 30, 2025 to holders of record on September 8, 2025 . The indicated annual dividend rate is $4.16 per share. About BD BD is one of the largest global... Read More

FRANKLIN LAKES, N.J. , July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2 , Bilal Muhsin has been named executive vice president and will become the president of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strategy. Mushin... Read More

FRANKLIN LAKES, N.J. , May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data registry for the Rotarex™ Atherectomy System to measure real-world outcomes for patients with peripheral artery disease (PAD). Known as "XTRACT," this prospective, multi-center, single-arm, post-market registry study will assess the... Read More

FRANKLIN LAKES, N.J. , May 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sachs 46 th Annual Global Healthcare Conference on Monday, June 9, 2025 at 2:00 pm Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the... Read More

FRANKLIN LAKES, N.J. , May 21, 2025 /PRNewswire/ -- First-of-their-kind studies published in The Lancet Oncology 1 and Cancer Medicine 2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (AMR) infections compared to all other non-cancer patients. Key Takeaways: The studies, led by the Cancer and AMR Consortium ,... Read More

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma FRANKLIN LAKES, N.J. , May 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies,... Read More

FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 7, 2025 to discuss the Company's financial results for its third quarter of fiscal year 2025, which ends on June 30, 2025, and to provide an update on its operations and strategy. The... Read More

Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35 , respectively Company updates full-year fiscal 2025 guidance and provides estimated tariff impact FRANKLIN LAKES, N.J. , May 1, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025... Read More

FRANKLIN LAKES, N.J. , April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 13, 2025 at 1:00 pm Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More

FRANKLIN LAKES, N.J. , April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on June 30, 2025 to holders of record on June 9, 2025 . The indicated annual dividend rate is $4.16 per share. About BD BD is one of the largest global medical... Read More

Phasix™ ST Umbilical Hernia Patch Leverages Same Surgical Technique as Permanent Mesh Procedures FRANKLIN LAKES, N.J. , April 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial launch of Phasix™ ST Umbilical Hernia Patch, the first and only fully absorbable... Read More

HemoSphere Alta™ Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical Situations FRANKLIN LAKES, N.J. , April 21, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence... Read More

FRANKLIN LAKES, N.J. , April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to discuss the Company's financial results for its second quarter of fiscal year 2025, which ended on March 31, 2025, and to provide an update on its operations and strategy. The... Read More

FRANKLIN LAKES, N.J. , March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture.... Read More

FRANKLIN LAKES, N.J. , March 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025 . Hayes, 64, is currently the executive chairman of the board of directors of RTX Corporation, the world's largest aerospace and defense company. He brings more than 30 years of... Read More

FRANKLIN LAKES, N.J. , March 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD's efforts to achieve Premarket Approval (PMA) from the... Read More

FRANKLIN LAKES, N.J. , Feb. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 8:45 a.m. Eastern Time Barclays 27 th Annual Global Healthcare Conference March 11, 2025 8:30 a.m. Eastern Time The live... Read More

Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic GAAP and adjusted diluted EPS of $1.04 and $3.43 grew 8.3% and 28.0%, respectively BD completes $750 million share repurchase to date in FY25 Company increases FY25 adjusted diluted EPS guidance at the midpoint while absorbing translational currency 1 FRANKLIN... Read More

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 strategy, will be well-positioned as a scaled, pure-play MedTech leader focused on attractive categories shaping the future of... Read More

FRANKLIN LAKES, N.J. , Jan. 28, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on March 31, 2025 to holders of record on March 10, 2025 . The indicated annual dividend rate is $4.16 per share. The company also announced it repurchased $750 million... Read More

FRANKLIN LAKES, N.J. & SAN DIEGO / Jan 23, 2025 / Business Wire / BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and... Read More

ROANOKE, Va. and FRANKLIN LAKES, N.J. , Jan. 22, 2025 /PRNewswire/ -- Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia , in partnership with BD, (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Carilion is the... Read More

FRANKLIN LAKES, N.J. , Jan. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, February 6, 2025 to discuss the Company's financial results for its first quarter of fiscal year 2025, which ended on December 31, 2024, and to provide an update on its operations and strategy.... Read More

83% Want More Accessible and Less Invasive Testing Options MISSISSAUGA, ON , Jan. 15, 2025 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the results of a new survey revealing that 74% of women in Canada have delayed a gynecology visit, with 83% wanting more... Read More

FRANKLIN LAKES, N.J. , Jan. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional investments in its U.S. manufacturing network to add capacity for critical medical devices, including syringes, needles and IV catheters, to meet the... Read More

BD Onclarity™ HPV assay adheres to new guidelines by identifying more individual types of HPV than any other test on the market FRANKLIN LAKES, N.J. , Jan. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the BD Onclarity™ HPV Assay has... Read More

FRANKLIN LAKES, N.J. , Jan. 10, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Pamela Spikner has been named senior vice president, chief accounting officer and controller, effective January 20 . In this role, Spikner will be responsible for all accounting policy and financial reporting for the company. She will report to Chris DelOrefice... Read More

Women Are Seeking More Convenience and Less Discomfort in Testing Options FRANKLIN LAKES, N.J. , Jan. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey, revealing that 72% of women in the United States have delayed... Read More

FRANKLIN LAKES, N.J. , Jan. 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2025 Annual Meeting of Shareholders (the "Annual Meeting") on Tuesday, January 28, 2025 , at 1:00 p.m. (ET) . As described in the proxy materials for the Annual Meeting previously distributed, shareholders as of the close of business on... Read More

FRANKLIN LAKES, N.J. and AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use... Read More

FRANKLIN LAKES, N.J. , Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve the previously disclosed investigation related to prior public disclosures and SEC reporting regarding the BD Alaris™ System, which was acquired by BD... Read More

BROWNSVILLE, Texas , Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved communities has officially launched in Texas . HPV is the cause of virtually all cervical cancers. The study is being conducted at... Read More

FRANKLIN LAKES, N.J. , Nov. 19, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7 th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024 , at 10:50 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the... Read More

Strong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic Q4 GAAP and adjusted diluted EPS from continuing operations of $1.45 and $3.81 grew 173.6% and 11.4%, respectively FY24 revenue of $20.2 billion increased 4.2% as reported and currency neutral, 4.6% adjusted currency-neutral, and 5.0% organic FY24 GAAP and adjusted... Read More

FRANKLIN LAKES, N.J. , Nov. 7, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an increase of 9.5% from the previous quarter. The dividend will be payable on December 31, 2024 to holders of record on December 9, 2024 . The indicated annual dividend rate for fiscal year 2025 is $4.16 per share. "This is the 53 rd... Read More

FRANKLIN LAKES, N.J. , Oct. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular Access System, enabling access for rapid delivery of fluids or medication in critical emergency situations. The procedure involves... Read More

MISSISSAUGA, ON , Oct. 29, 2024 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today Health Canada approval of the BD Onclarity™ HPV Assay for human papillomavirus (HPV) testing for the use with self-collected vaginal specimens at home. Self-collected samples... Read More

FRANKLIN LAKES, N.J. , Oct. 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named as one of the 100 Best Corporate Citizens of 2024 by 3BL, ranking second in the health care equipment and services industry for its second consecutive year. The 100 Best Corporate Citizens list recognizes outstanding environmental, social and... Read More

Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J. , Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch... Read More

Announces Dates for Fiscal 2025 Quarterly Earnings Webcasts FRANKLIN LAKES, N.J. , Oct. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its fiscal 2024 fourth quarter and full year on Thursday, Nov. 7, 2024 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be... Read More

No admission of liability or wrongdoing; settlement structured to eliminate uncertainty for all stakeholders related to settled cases. Settlement amount within current product litigation reserve and will be paid out over a multi-year period. Settlement will not change BD's cash flow goals or capital allocation strategy. FRANKLIN LAKES, N.J. , Oct. 2, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a... Read More

FRANKLIN LAKES, N.J. , Sept. 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help health systems better identify incidents of controlled substance diversion in... Read More

LE PONT-DE-CLAIX, France , Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak™ Glass Prefillable Syringe platform to... Read More

Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools Combination of leading monitoring and infusion platforms enables future innovation opportunities for closed–loop monitoring and treatment, integrating combined company data sets... Read More

Emphasizes Value of Domestic Production of Critical Medical Devices FRANKLIN LAKES, N.J. , Aug. 22, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today celebrated the 75th anniversary of its manufacturing operations in Columbus, Neb. , and reinforced the need... Read More

FRANKLIN LAKES, N.J. , Aug. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named executive vice president and president of the Life Sciences segment for BD, effective Aug. 20, 2024 , and will serve as a member of... Read More

FRANKLIN LAKES, N.J. , Aug. 8, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024 at 8:45 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be... Read More

Strong Margin Execution Drives Performance in Quarter Revenue of $5.0 billion as reported, adjusted revenue of $5.1 billion , driven by strong organic revenue growth GAAP and adjusted diluted EPS of $1.68 and $3.50 grew 23.5% and 18.2%, respectively Year-to-date Cash from Continuing Operations grew 60% to $2.7 billion and Free Cash Flow grew over 100% to $2.2 billion , increasing $1.0 billion and $1.2 billion since the prior... Read More

Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a global collaboration agreement to develop, manufacture and... Read More

FRANKLIN LAKES, N.J. , July 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on September 30, 2024 to holders of record on September 9, 2024 . The indicated annual dividend rate is $3.80 per share. About BD BD is one of the largest global... Read More

Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to a U.S. FDA... Read More

FRANKLIN LAKES, N.J. , July 10 , 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2 science-based greenhouse gas (GHG) emissions reduction targets for FY 2023 by 5 percentage points and received approval for near and long-term science-based emissions reduction targets from the Science Based Target initiative... Read More

FRANKLIN LAKES, N.J. , July 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 on Thursday, August 1, 2024 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More

BD Rhapsody™ ATAC-Seq Assay Helps Researchers Understand DNA Regulation and Enable Advancements in Precision Medicine FRANKLIN LAKES, N.J. , June 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial launch of a new single-cell research... Read More

FRANKLIN LAKES, N.J. , June 20, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the following dates: Third Quarter Fiscal 2024 —Thursday, August 1, 2024 at 8:00 a.m. (ET) Fourth Quarter Fiscal 2024 — Thursday, November 7, 2024 at 8:00 a.m. (ET) BD will issue a detailed... Read More

Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands BD's portfolio of smart connected care solutions with complementary and broad set of leading monitoring technologies, advanced... Read More

FRANKLIN LAKES, N.J. , May 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot... Read More

Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic Q2 GAAP and adjusted diluted EPS of $1.85 and $3.17 grew 20.9% and 10.8%, respectively Year-to-date Cash from Continuing Operations of $1.4 billion and Free Cash Flow of $1.1 billion increased $785 million and over $900 million , respectively... Read More

FRANKLIN LAKES, N.J. , April 30, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on June 28, 2024 to holders of record on June 10, 2024 . The indicated annual dividend rate is $3.80 per share. About BD BD is one of the largest global medical... Read More

FRANKLIN LAKES, N.J. , April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the... Read More

FRANKLIN LAKES, N.J. , April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. BD also garnered honors for "Excellence in... Read More

New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery FRANKLIN LAKES, N.J. , April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable... Read More

FRANKLIN LAKES, N.J. , April 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More

Most Americans Unaware of Challenges from Common Hospital Procedures FRANKLIN LAKES, N.J. , March 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey conducted by The Harris Poll that reveals that many patients receive... Read More

FRANKLIN LAKES, N.J. , March 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies . "At BD, innovation is about a mindset of excellence and continuous improvement, boldly challenging ourselves to think ahead and partnering with our customers to understand the evolving needs of the... Read More

FRANKLIN LAKES, N.J. , March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration (FDA) Safety Communication , which provided important updates on FDA's ongoing evaluation of certain plastic syringes: Eric Borin , president of BD Medication Delivery Solutions... Read More

COPENHAGEN, Denmark , March 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood collection tubes without compromising hygiene, safety or quality of the material. BD partnered with Odense University Hospital, the Health Innovation Centre of Southern Denmark ,... Read More

Results Show Clinical Workflow, Operational Efficiency and Financial Improvements When Using Automated Dispensing Cabinets FRANKLIN LAKES, N.J. , March 13, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data from a research study evaluating... Read More

First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J. , March 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the... Read More

FRANKLIN LAKES, N.J. , Feb. 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Dave Hickey has informed the company of his intent to retire from BD, effective July 1 . Hickey is currently executive vice president and president of the Life Sciences segment for BD, a position he has held since January 2021 . Prior to his current role,... Read More

First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing SINGAPORE , Feb. 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic partnership with Camtech Health, a digital health company focused on... Read More

FRANKLIN LAKES, N.J. , Feb. 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2024 Unplugged Medtech and Life Sciences Access Day February 29, 2024 8:00 am Eastern Time Barclays 26 th Annual Global Healthcare Conference March 13, 2024 9:30 am Eastern Time The live webcasts... Read More

FRANKLIN LAKES, N.J. , Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series — which will highlight BD solutions that help clinicians treat Peripheral Vascular Disease — on Monday, February 26, 2024 , at 3:00 PM Eastern Time . The BD Innovates series spotlights BD's... Read More

Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organic Q1 GAAP and adjusted diluted EPS from continuing operations of $0.96 and $2.68 , respectively Company raises full-year adjusted EPS guidance and midpoint of organic revenue growth guidance FRANKLIN LAKES, N.J. , Feb. 1, 2024 /PRNewswire/ -- BD... Read More

AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah , Jan. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Techcyte, a world... Read More

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates NAIROBI, Kenya , Jan. 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with the Kenyan Government through the National Cancer Institute-Kenya to advance access to critical cancer diagnostics... Read More

FRANKLIN LAKES, N.J. , Jan. 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on March 29, 2024 to holders of record on March 8, 2024 . The indicated annual dividend rate is $3.80 per share. About BD BD is one of the largest global medical... Read More

Companies to automate a critical step of high-throughput single-cell multiomics experiments FRANKLIN LAKES, N.J. , Jan. 23, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of... Read More

Survey Conducted in the US, UK and Sweden Exposes Lack of Education on Options and Unclear Guidance on HPV Testing FRANKLIN LAKES, N.J. , Jan. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a Harris Poll survey of women in the... Read More

FRANKLIN LAKES, N.J. , Jan. 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2024 , at 1:00 p.m. (ET) . The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the... Read More

FRANKLIN LAKES, N.J. , Jan. 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2024 on Thursday, February 1, 2024 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More

FRANKLIN LAKES, N.J. , Dec. 22, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 10:30 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More

Company Reinforces its Longstanding Commitment to Help Improve Health Equity and Expand Access to Care Among Vulnerable Populations FRANKLIN LAKES, N.J. , Dec. 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it signed the World Economic... Read More

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J. , Dec. 7, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has... Read More

FRANKLIN LAKES, N.J. , Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will highlight its Pharmaceutical Systems business on Monday, December 11, 2023 , at 11:30 am Eastern Time . The BD Innovates series spotlights BD's innovation, products and pipeline in... Read More

Company Committed to Support U.S. Health Care Needs FRANKLIN LAKES, N.J. , Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety Communication on evaluation of... Read More

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success FRANKLIN LAKES, N.J. , Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, advanced ultrasound... Read More

FRANKLIN LAKES, N.J. , Nov. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman , MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023 . Dr. Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical... Read More

FRANKLIN LAKES, N.J. , Nov. 14, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 6 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 8:20 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4 revenue from base business (which excludes COVID-only diagnostic testing) grew 7.3% as reported, 6.3% currency-neutral or 7.0% organic Q4 GAAP and adjusted diluted EPS from continuing operations of $0.53 and $3.42 , respectively FY23 revenue of $19.4 billion increased... Read More

FRANKLIN LAKES, N.J. , Nov. 9, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.95 per common share, an increase of 4.4% from the previous quarter. The dividend will be payable on December 29, 2023 to holders of record on December 8, 2023 . The indicated annual dividend rate for fiscal year 2024 is $3.80 per share. "This is the 52nd... Read More

New Peripheral Line Draw Solution Delivers First and Only Compatibility with Integrated Catheters, Bringing Elevated Standard of Care to More U.S. Hospitals FRANKLIN LAKES, N.J. , Nov. 2, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched new... Read More

Company Ranks Top 2 in Healthcare Equipment and Services Industry FRANKLIN LAKES, N.J. , Oct. 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named to the 100 Best Corporate Citizens List by 3BL, which recognizes outstanding environmental, social and governance (ESG) transparency and performance among 1,000 of the largest U.S.... Read More

FRANKLIN LAKES, N.J. , Oct. 17, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Greg Rodetis , currently BD senior vice president and treasurer will also add head of investor relations to his responsibilities, effective immediately. In this expanded role, Greg will continue as company treasurer and also lead all aspects of communicating... Read More

All Used Injection Devices Recycled; Next Stage of Pilot to Expand Regionally, Add Medical Devices FRANKLIN LAKES, N.J. and RUTLAND, Vt . , Oct. 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Casella Waste Systems, Inc. (Nasdaq: CWST) (Casella), a solid waste, recycling, and resource management services company, today announced the most recent results... Read More

FRANKLIN LAKES, N.J. , Oct. 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023 fourth quarter and full year financial results on Thursday, November 9, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related... Read More

Recognition underscores company's commitment to transparency and values FRANKLIN LAKES, N.J. , Sept. 19, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been ranked in the top 10 for overall transparency and awarded Best Code of Conduct among S&P 250 companies in the fifth annual U.S. Transparency Awards by Labrador, a global... Read More

CARLSBAD, Calif. , Sept. 7, 2023 /PRNewswire/ -- Navigate BioPharma Services, Inc. , a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, to explore opportunities to develop and commercialize... Read More

FRANKLIN LAKES, N.J. , Aug. 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo Healthcare Conference September 6, 2023 8:45 a.m. EDT Morgan Stanley 21 st Annual Global Healthcare Conference September 12, 2023 8:50 a.m. EDT The live webcasts of BD's presentations can... Read More

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™ Infusion System Revenue of $4.9 billion increased 5.1% as reported and 6.3% on a currency-neutral basis Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.7% as reported, 7.9% currency-neutral or 6.3% organic GAAP and adjusted diluted EPS from... Read More

Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J. , Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k)... Read More

FRANKLIN LAKES, N.J. , July 25, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on September 29, 2023 to holders of record on September 8, 2023 . The indicated annual dividend rate is $3.64 per share. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of... Read More

FRANKLIN LAKES, N.J. , July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical officer, she provided... Read More

FRANKLIN LAKES, N.J. , July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k) clearance for the updated BD Alaris™ Infusion System : "Hello, I'm Tom Polen , chairman, CEO and president of BD. I wanted to share some exciting news and explain what it means for our company and our... Read More

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System's... Read More

Company Expands its ESG Focus Areas to Include Advancing Health Equity in Under-Resourced Communities FRANKLIN LAKES, N.J. , July 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its Fiscal Year 2022 Environmental, Social and Governance (ESG)... Read More

Top Score on Disability Equality Index Demonstrates Ongoing Progress in Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J. , July 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its recognition as a Best Place to Work for Disability Inclusion for the fifth consecutive year. This marks BD's second consecutive... Read More

FRANKLIN LAKES, N.J. , July 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2023 on Thursday, August 3, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More

Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets FRANKLIN LAKES, N.J. , June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (NYSE: STE) for $540 million . The divestiture will include V. Mueller™,... Read More

BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics FRANKLIN LAKES, N.J. , June 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial... Read More

BD PosiFlush™ SafeScrub Streamlines Clinical Workflow for Disinfecting and Flushing IV Catheters to Help Improve Patient Care FRANKLIN LAKES, N.J. , May 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced expanded customer availability of an all-in-one... Read More

BD FACSDiscover™ S8 Cell Sorter First to Combine Spectral Flow Cytometry with Real-Time Imaging Technology FRANKLIN LAKES, N.J. , May 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting... Read More

BD Kiestra™ MRSA Imaging Application Helps Enhance Microbiology Laboratory Efficiency and Workflow FRANKLIN LAKES, N.J. , May 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA)... Read More

Five organizations are collaborating to evaluate recycling program for blood collection tubes at Odense University Hospital COPENHAGEN, Denmark , May 8, 2023 /PRNewswire/ -- A new health care sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical waste as part of the participants' sustainability goals and Denmark's Climate Action Strategy. The pilot program is... Read More

BD 2025 Strategic Investments Driving Growth and Advancing Innovation; Company Raises Mid-point of Revenue and Adjusted EPS Guidance Ranges Revenue of $4.8 billion increased 1.5% as reported and 4.1% on a currency-neutral basis Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.0% as reported, 8.7% currency-neutral GAAP and adjusted diluted EPS from continuing operations of $1.53 and $2.86 ,... Read More

FRANKLIN LAKES, N.J. , May 3, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a "Noteworthy Company" in DiversityInc's annual ranking of the top U.S. companies for diversity. Since 2001, the DiversityInc Top 50 survey has been the external validator for large U.S. employers that model fairness in their talent strategy,... Read More

FRANKLIN LAKES, N.J. , April 26, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 11:00 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the... Read More

FRANKLIN LAKES, N.J. , April 25, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 2023 . The indicated annual dividend rate is $3.64 per share. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health... Read More

Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J. , April 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the leading employers in the U.S. for diversity. BD was named to the list based on survey responses from approximately... Read More

FRANKLIN LAKES, N.J. , April 19, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted online by The Harris Poll, reporting that women feel less knowledgeable about testing and treatment options for sexually transmitted... Read More

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. , April 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound... Read More

FRANKLIN LAKES, N.J. , April 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2023 on Thursday, May 4, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More

FRANKLIN LAKES, N.J. , April 3 , 2023 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Michelle Quinn has been named executive vice president and general counsel for the company, effective April 1 . Quinn has responsibility for leading the Law Group at BD. She... Read More

BD Vaginal Panel on BD COR™ System Tests for Multiple Common Types of Vaginitis Using Only One Swab, One Test FRANKLIN LAKES, N.J. , March 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S.... Read More

FRANKLIN LAKES, N.J. , March 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 9:00 am Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be... Read More

The 3 rd Generation BD Kiestra™ Total Lab Automation System Offers Flexible Instrument to Optimize Lab Space and Streamline Workflow FRANKLIN LAKES, N.J. , Jan. 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a new, robotic track system for... Read More

Assay for Research and Clinical Use Now Globally Available for the BD MAX™ System FRANKLIN LAKES, N.J. , Jan. 9, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec have announced Emergency Use Authorization (EUA) from the U.S. Food and Drug... Read More

FRANKLIN LAKES, N.J. , Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 24, 2023 , at 1 p.m. (ET) . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be... Read More

FRANKLIN LAKES, N.J. , Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat (Sam) Khichi , who has informed the company of his intent to depart BD for a new... Read More

FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation... Read More

FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton , Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022 , among 872 U.S. women ages 18 to 64 years old, that indicate a significant gap in... Read More

FRANKLIN LAKES, N.J. , Dec. 20, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 12:45 pm Eastern Time . The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event... Read More

FRANKLIN LAKES, N.J. , Dec. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its second annual Global Inclusion, Diversity and Equity (ID&E) Report for fiscal year 2022. The report, titled "We are the makers of possible," is an... Read More

FRANKLIN LAKES, N.J. , Dec. 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named among the top 25% of Newsweek's list of America's Most Responsible Companies. This is the fourth consecutive year that the company has been named to the list. The list recognizes the top 500 most responsible companies in the U.S. based on... Read More